Tau-based biomarker tracks Alzheimer's progre

Researchers at Washington University School of Medicine in St. Louis and Lund University in Sweden have discovered a biomarker for Alzheimer's disease in the cerebrospinal fluid known as MTBR-tau243 can be used to track the progression of the disease and could speed drug development.

Related Keywords

Sweden ,Eli Lilly ,Roche Genentech ,Cajal Neurosciences ,Gemma Salvad ,Randallj Bateman ,Kanta Horie ,Lund University In ,Siemens ,Method Of Research ,Geras Solutions ,N Diagnostics To Washington University ,Genentech ,Washington University ,Ge Healthcare ,Lund University Oskar Hansson ,Washington University School Of Medicine ,Novartis ,Pfizer ,Knight Alzheimer Disease Research Center ,Bristol Myers Squibb ,Washington University School ,Lund University ,Nature Medicine ,Joanne Knight Distinguished Professor ,Oskar Hansson ,Detect Endogenously Cleaved Fragments ,Avid Radiopharmaceuticals ,